A novel approach to producing lightweight, high-bulk insulating sheets from wood pulp using foam wet-laid papermaking techniques. Building on proven molded pulp products like egg cartons, this method uses frothy stock preparation to increase bulk and thermal insulation properties for sustainable packaging and building material applications.
This solution proposes a method for producing low-density insulating sheets using wood pulp through an innovative foam wet-laid papermaking process. Traditional molded pulp products such as egg cartons, plant pots, and pallets have long demonstrated that wet-formed wood fiber structures can serve as effective thermal barriers. This approach extends that proven concept by introducing a frothy stock preparation step to significantly increase the bulk of the resulting material, creating lightweight sheets with enhanced insulation properties.
The technology addresses growing demand for sustainable, bio-based alternatives to synthetic foam insulation materials. Potential applications include thermal barriers for packaging (similar to microflute corrugated board used over coffee cups), building insulation, and other lightweight protective materials. By optimizing the wet-laid process with effervescent or foam-forming techniques, manufacturers can achieve higher bulk structures while maintaining the environmental advantages of wood fiber feedstock.
Process approach:
Key features:
The concept is at an early research and proof-of-concept stage. The underlying wet-formed low-density wood fiber structures have been commercially validated through decades of molded pulp products including egg cartons and packaging materials. The novel foam-forming extension to increase bulk and insulation properties requires further validation. A standard handsheet former can be used to demonstrate the concept by preparing frothy stock from chosen pulp and measuring resulting bulk and physical properties. The research team at Georgia Tech's Renewable Bioproducts Institute has the capability to conduct these initial validation experiments.
Georgia Institute of Technology is a large, technology‑focused public research university in Atlanta with a strong applied research culture. Industry engages through the Georgia Tech Research Institute for contract R&D, a Midtown innovation district with co‑located corporate labs, and a statewide manufacturing extension to support scale‑up. A long‑standing partnership with a major academic medical center enables clinical translation, and a large co‑op program delivers a steady talent pipeline. Research is backed by competitive federal funding from NSF, NIH, DOE, DoD, and NASA. Technology commercialization is managed by the Georgia Tech Research Corporation, with dedicated licensing, corporate contracting, and startup support.